Press Releases
ST JULIANS, Malta, June 4, 2024 /PRNewswire/ -- Reference is made to today's announcement from Gaming Innovation Group Inc. (GiG) regarding a SEK 100 million directed share issue.
Jonas Warrer Petersen Holding ApS, a company owned by Jonas Warrer, Group CEO and primary insider of Gaming Innovation Group Inc. (GiG), has participated in the share issue with 18,338 shares at a price of SEK 31.00 per share. After this transaction, Jonas Warrer holds 60,000 options in GiG... (continue reading...)
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Toyota Motor Corporation (NYSE: TM) resulting from allegations that Toyota may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Toyota securities you may be entitled to compensation without payment of any out of pocket fees... (continue reading...)
DUBAI, UAE - (NewMediaWire) - June 04, 2024 - Blackwell 3D Construction Corp. (OTC: BDCC) ("Blackwell 3D or the "Company"), an innovative 3D house printing technology company focused on revolutionizing the construction industry by printing environmentally friendly 3D homes in a fraction of the time and at a fraction of the cost of traditional homes, is pleased to unveil the formation of its subsidiary in the Philippines, dedicated to advancing affordable housing... (continue reading...)
PARIS, France, June 4, 2024 – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, held its ordinary and extraordinary general meeting of shareholders on May 30, 2024 (the “General Meeting”), which was chaired by Mr. Marc de... (continue reading...)
BOSTON--(BUSINESS WIRE)-- Astria Therapeutics, Inc. (Nasdaq: ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 40,000 shares of Astria’s common stock on June 3, 2024 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an... (continue reading...)
More Press Releases
View Older Stories-
Herc Holdings Announces Pricing of Upsized $800 Million Senior Unsecured Notes Offering
-
KB Home to Release 2024 Second Quarter Earnings on June 18, 2024
-
ASPCA Encourages Public to Be Part of the "Rescue Effect" By Adopting and Fostering Shelter Animals During Adopt a Shelter Cat Month in June
-
PennantPark Floating Rate Capital Ltd. Upsizes Credit Facility to $611 Million
-
Modernizing Higher Education: Info-Tech Research Group Identifies Four Exponential IT Priorities to Improving Academic Delivery
-
Nasdaq May 2024 Volumes
-
Stitch Fix Announces Third Quarter of Fiscal Year 2024 Financial Results
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
Hewlett Packard Enterprise Reports Fiscal 2024 Second Quarter Results
-
CrowdStrike Reports First Quarter Fiscal Year 2025 Financial Results
-
Verint Announces Strong Q1 FYE 2025 Results
-
HashiCorp and AWS sign strategic collaboration agreement to expand joint product and go-to-market initiatives
-
Sportsman’s Warehouse Holdings, Inc. Announces First Quarter 2024 Financial Results
-
PagerDuty Announces Integration with Snowflake Trail to Improve Observability Workflows
-
EZCORP to Participate in June Conferences
-
Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
-
Skechers to Present at the Evercore ISI Consumer and Retail Conference on June 11th
-
Oracle Sets the Date for its Fourth Quarter Fiscal Year 2024 Earnings Announcement
-
Intel and Apollo Agree to Joint Venture Related to Intel’s Fab 34 in Ireland
-
Rogers Corporation to Participate in Upcoming Investor Conferences
-
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
-
Purple to Participate in Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
-
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (Nasdaq:BPTH) Q1 24
-
Myers Industries Announces Quarterly Dividend
-
Nextracker to Present at the J.P. Morgan Energy, Power & Renewables Conference
-
Root, Inc. to Participate in the TD Financial Services & Fintech Summit
-
Allison Transmission Announces G. Frederick Bohley as New Chief Operating Officer
-
Consolidated Water Announces Settlement of Dispute with Mexico Regarding Playas de Rosarito, Baja California Desalination Project
-
Agilysys to Participate in Baird 2024 Global Consumer, Technology & Services Conference
-
RGP Appoints Roger Carlile to Its Board of Directors
-
ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
-
Repare Therapeutics Announces Fast Track Designation Granted by the FDA for Lunresertib in Combination with Camonsertib for the Treatment of Platinum-Resistant Ovarian Cancer
-
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
-
Acquisition of Fusion Pharmaceuticals Completed
-
Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference
-
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
-
TD SYNNEX to Announce Second Quarter Fiscal 2024 Results on June 25, 2024
-
Root, Inc. to Participate in the TD Financial Services & Fintech Summit
-
Mirion Announces Updated Time of Presentation at Jefferies’ 2024 Global Healthcare Conference
-
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
-
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
-
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
-
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
-
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
-
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
-
TekSynap Celebrates VA LAN CCT (IRP) Award
-
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
-
Aston Minerals Announces Participation in THE Mining Investment Event of the North, Canada's Only Tier I Global Mining Investment Conference
-
World Financial Split Corp. Declares Quarterly Preferred Share Distribution